Mayne Pharma (ASX:MYX)
ASX announcement history & article coverage
Transparent by design.
Announcments by Mayne Pharma (ASX:MYX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification regarding unquoted securities - MYX
Notification regarding unquoted securities - MYX
Notification regarding unquoted securities - MYX
Notification regarding unquoted securities - MYX
Initial Director's Interest Notice
Mayne Pharma appoints new Non-Executive Director
Change in substantial holding
Change in substantial holding
Final Director's Interest Notice
Mayne Pharma receives $14.4m for legal costs from Cosette
Mayne Pharma receives $14.4 million legal costs payment from Cosette Pharmaceuticals following court ruling
MYX Jefferies Global Healthcare Conference Presentation
New DistributeRx partnership with Resilia Pharmaceuticals
Mayne Pharma to present at Jefferies Healthcare Conference
Court awards MYX $13.27m for legal costs from Cosette
Mayne Pharma awarded $13.27M legal costs from Cosette Pharmaceuticals
Mayne Pharma announces expansion of Adelaide Apothecary
Mayne Pharma 3Q investor presentation
Notification of cessation of securities - MYX
Further details re equity instruments to be issued to CEO
Mayne Pharma reports unaudited 3Q FY26 results
Mayne Pharma posts 1% revenue growth and strong cash flow with DistributeRx launch exceeding forecasts
